Clinical trials recruiting for Chemotherapy-induced Peripheral Neuropathy (CIPN)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Ozone therapy | 2 |
| GM1 | 1 |
Self-screener
Recruiting trials
- Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients
- GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
- Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
- Multimodal Assessment of Cryotherapy for Paclitaxel-Induced Neuropathy
- Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
- The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy
Related conditions
Trials recruiting for Chemotherapy-induced Peripheral Neuropathy (CIPN) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Chemotherapy-induced Peripheral Neuropathy (CIPN) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.